Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ueda, George"" wg kryterium: Autor


Tytuł :
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
Autorzy :
Martin, Jacob T.Aff1, Aff2
Cottrell, Christopher A.Aff2, Aff3
Antanasijevic, AleksandarAff2, Aff3
Carnathan, Diane G.Aff2, Aff4, Aff5
Cossette, Benjamin J.Aff1, Aff2
Enemuo, Chiamaka A.Aff4, Aff5
Gebru, Etse H.Aff4, Aff5
Choe, YuryAff4, Aff5
Viviano, FedericoAff4, Aff5
Fischinger, StephanieAff6, Aff7
Tokatlian, TalarAff1, Aff2
Cirelli, Kimberly M.Aff2, Aff8
Ueda, GeorgeAff9, Aff10
Copps, Jeffrey
Schiffner, TorbenAff2, Aff11
Menis, SergeyAff2, Aff11
Alter, Galit
Schief, William R.Aff2, Aff6, Aff11
Crotty, ShaneAff2, Aff8, Aff12
King, Neil P.Aff9, Aff10
Baker, DavidAff9, Aff10, Aff13
Silvestri, GuidoAff2, Aff4, Aff5
Ward, Andrew B.Aff2, Aff3, Aff11
Irvine, Darrell J.Aff1, Aff2, Aff6, Aff13, Aff14, Aff15
Pokaż więcej
Źródło :
npj Vaccines. 5(1)
Czasopismo naukowe
Tytuł :
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
Autorzy :
Antanasijevic, Aleksandar (AUTHOR)
Ueda, George (AUTHOR)
Brouwer, Philip J. M. (AUTHOR)
Copps, Jeffrey (AUTHOR)
Huang, Deli (AUTHOR)
Allen, Joel D. (AUTHOR)
Cottrell, Christopher A. (AUTHOR)
Yasmeen, Anila (AUTHOR)
Sewall, Leigh M. (AUTHOR)
Bontjer, Ilja (AUTHOR)
Ketas, Thomas J. (AUTHOR)
Turner, Hannah L. (AUTHOR)
Berndsen, Zachary T. (AUTHOR)
Montefiori, David C. (AUTHOR)
Klasse, Per Johan (AUTHOR)
Crispin, Max (AUTHOR)
Nemazee, David (AUTHOR)
Moore, John P. (AUTHOR)
Sanders, Rogier W. (AUTHOR)
King, Neil P. (AUTHOR)
Pokaż więcej
Źródło :
PLoS Pathogens. 8/11/2020, Vol. 16 Issue 8, p1-36. 36p.
Czasopismo naukowe
Tytuł :
4427 Angiopoietin F-domain valency determines outcome of Tie2 receptor engagement and accelerates angiogenesis in tissue regeneration.
Autorzy :
Zhao, Yan Ting
Fallas, Jorge
Saini, Shally
Ueda, George
Somasundaram, Logeshwaran
Zhou, Ziben
Seller, Drew
Baker, David
Ruohola-Baker, Hannele
Pokaż więcej
Temat :
VALENCE (Chemistry)
TISSUE physiology
INFLAMMATORY mediators
TISSUES
CELL populations
NEUROGLIA
NEOVASCULARIZATION
Źródło :
Journal of Clinical & Translational Science; 2020Supplement1, Vol. 4, p2-2, 1p
Czasopismo naukowe
Tytuł :
Quadrivalent influenza nanoparticle vaccines induce broad protection.
Autorzy :
Boyoglu-Barnum S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ellis D; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Graduate Program in Molecular and Cellular Biology, University of Washington, Seattle, WA, USA.
Gillespie RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Hutchinson GB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Moin SM; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Acton OJ; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Macromolecular Structure Laboratory, The Francis Crick Institute, London, UK.
Ravichandran R; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Murphy M; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Pettie D; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Matheson N; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Carter L; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Creanga A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Watson MJ; Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Kephart S; Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Ataca S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Vaile JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ueda G; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Crank MC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Stewart L; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Lee KK; Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Guttman M; Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Baker D; Institute for Protein Design, University of Washington, Seattle, WA, USA.; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.
Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA.
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .
King NP; Institute for Protein Design, University of Washington, Seattle, WA, USA. .; Department of Biochemistry, University of Washington, Seattle, WA, USA. .
Kanekiyo M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .
Pokaż więcej
Źródło :
Nature [Nature] 2021 Mar 24. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Designed proteins assemble antibodies into modular nanocages.
Autorzy :
Divine R; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Dang HV; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Ueda G; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Fallas JA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Vulovic I; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Sheffler W; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Saini S; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Zhao YT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Oral Health Sciences, School of Dentistry, University of Washington, Seattle, WA 98195, USA.
Raj IX; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Morawski PA; Benaroya Research Institute, Seattle, WA 98101, USA.
Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Homad LJ; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Wan YH; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Tooley MR; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Seeger F; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Etemadi A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Fahning ML; Benaroya Research Institute, Seattle, WA 98101, USA.
Lazarovits J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Roederer A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Stewart L; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Mazloomi M; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
King NP; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Campbell DJ; Benaroya Research Institute, Seattle, WA 98101, USA.
McGuire AT; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.; University of Washington, Department of Global Health, Seattle, WA, USA.
Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.; University of Washington, Department of Global Health, Seattle, WA, USA.
Ruohola-Baker H; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Mathieu J; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA.
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Baker D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 Dec 01. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Preprint

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies